In one aspect the disclosure provides formulations that stabilize proteins wherein the formulations comprise a buffer. In some embodiments the buffer comprises potassium mono hydrogen phosphate and potassium di hydrogen phosphate or the buffer comprises sodium mono hydrogen phosphate and sodium di hydrogen phosphate. In some embodiments the protein is a therapeutic protein. In some embodiments the therapeutic protein is antithrombin.
